▲Image source: Getty Image Bank. [메디칼업저버 박선혜 기자] SGLT-2 inhibitors, which were developed as anti-diabetes drugs and have expanded to kidney drugs, are adding benefits to the kidneys as research has shown they can also reduce the risk of kidney stones. As a result of comparing the risk of kidney stones by the antidiabetic agent […]
The post SGLT-2 Inhibitors Found to Reduce Risk of Kidney Stones appeared first on News Directory 3.